Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:40 PM
Ignite Modification Date:
2025-12-24 @ 10:40 PM
NCT ID:
NCT00414635
Eligibility Criteria:
Inclusion Criteria:
* Age 18 years or older
* CD4 count \> or = 200
* Viral load \< 50
* Treatment with a regimen containing efavirenz and tenofovir and lamivudine or emtricitabine for at least 90 days prior to screening
Exclusion Criteria:
* Detectable HIV RNA on an ultrasensitive assay within the 90 days preceding screening
* Prior evidence of intermediate or high level resistance to efavirenz, tenofovir or cytidine analogues
* Hepatitis B infection
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT00414635
Study Brief:
Protocol Section:
NCT00414635